Medicus Pharma Stock (NASDAQ:MDCX)

Financials Chart

Previous Close

$4.09

52W Range

$1.80 - $4.99

50D Avg

$3.60

200D Avg

$3.08

Market Cap

$47.39M

Avg Vol (3M)

$64.54K

Beta

5.56

Div Yield

-

MDCX Company Profile

Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets, with an emphasis on non-invasive treatments for skin cancer.

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

CA

Employees

-

IPO Date

Nov 15, 2024

Website

MDCX Performance

MDCX Financial Summary

	Dec 24	Dec 23	Dec 22
Revenue	-	-	-
Operating Income	$-11.18M	$-4.73M	$-978.42K
Net Income	$-10.62M	$-5.31M	$-1.69M
EBITDA	$-10.25M	$-2.66M	$-1.17M
Basic EPS	$-1.10	$-1.53	$-0.88
Diluted EPS	$-1.10	$-1.53	$-0.21

Fiscal year ends in Dec 24 | Currency in USD